Highways and Detours in the Realm of Photodynamic Therapy

Photodynamic therapy (PDT) has been a topic of interest since the first report in 1900 but has yet to become a ‘mainstream’ treatment protocol in the medical field. There are clear indications for which PDT might be the ‘method of choice’, but it is unlikely that there will be protocols for the trea...

Full description

Bibliographic Details
Main Authors: David Kessel, Qian Peng
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/6/3119
_version_ 1797240781243678720
author David Kessel
Qian Peng
author_facet David Kessel
Qian Peng
author_sort David Kessel
collection DOAJ
description Photodynamic therapy (PDT) has been a topic of interest since the first report in 1900 but has yet to become a ‘mainstream’ treatment protocol in the medical field. There are clear indications for which PDT might be the ‘method of choice’, but it is unlikely that there will be protocols for the treatment of systemic disease. This report discusses recent developments for promoting PDT efficacy, in the context of what is already known. Factors that can limit the scope of these applications are also indicated. Among the more interesting of these developments is the use of formulation techniques to target specific organelles for photodamage. This can enhance responses to PDT and circumvent situations where an impaired death pathway interferes with PDT efficacy.
first_indexed 2024-04-24T18:12:53Z
format Article
id doaj.art-d7ea15a860104d1cbf603daaa7b087e3
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-24T18:12:53Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d7ea15a860104d1cbf603daaa7b087e32024-03-27T13:45:04ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-03-01256311910.3390/ijms25063119Highways and Detours in the Realm of Photodynamic TherapyDavid Kessel0Qian Peng1Department of Pharmacology, Wayne State University School of Medicine, 540 E. Canfield Street, Detroit, MI 48201, USADepartment of Pathology, Oslo University Hospital, N-0310 Oslo, NorwayPhotodynamic therapy (PDT) has been a topic of interest since the first report in 1900 but has yet to become a ‘mainstream’ treatment protocol in the medical field. There are clear indications for which PDT might be the ‘method of choice’, but it is unlikely that there will be protocols for the treatment of systemic disease. This report discusses recent developments for promoting PDT efficacy, in the context of what is already known. Factors that can limit the scope of these applications are also indicated. Among the more interesting of these developments is the use of formulation techniques to target specific organelles for photodamage. This can enhance responses to PDT and circumvent situations where an impaired death pathway interferes with PDT efficacy.https://www.mdpi.com/1422-0067/25/6/3119photodynamicphotosensitizationcancer
spellingShingle David Kessel
Qian Peng
Highways and Detours in the Realm of Photodynamic Therapy
International Journal of Molecular Sciences
photodynamic
photosensitization
cancer
title Highways and Detours in the Realm of Photodynamic Therapy
title_full Highways and Detours in the Realm of Photodynamic Therapy
title_fullStr Highways and Detours in the Realm of Photodynamic Therapy
title_full_unstemmed Highways and Detours in the Realm of Photodynamic Therapy
title_short Highways and Detours in the Realm of Photodynamic Therapy
title_sort highways and detours in the realm of photodynamic therapy
topic photodynamic
photosensitization
cancer
url https://www.mdpi.com/1422-0067/25/6/3119
work_keys_str_mv AT davidkessel highwaysanddetoursintherealmofphotodynamictherapy
AT qianpeng highwaysanddetoursintherealmofphotodynamictherapy